CXCR4 and acute myeloid leukemia: The biological basis explaining this poor survival, when blasts have high CD123 expression, is enhanced signaling via the IL-3R in the CD123 overexpressing AML LSCs, resulting in increased proliferation and cell viability and decreased CXCR4 expression[30].